Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 501–553 of 553
Zhang, Y., Miao, Y., Xiong, X., Tan, J., Han, Z., Chen, F., Lei, P., & Zhang, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23512720
Understanding astrocyte-derived extracellular vesicles in health and disease
White, K. (2024) · Nottingham ePrints (University of Nottingham)
Pait, M. C. (2023) · WakeSpace Scholarship (Wake Forest University)
Abreu, L. K. S. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Murata, H. (2021) · eScholarship (California Digital Library) · Cited by 1
Shao, W., Liu, X., Chen, L., Zhu, X., Wu, Q., Bu, C., Zheng, F., Yu, G., Hu, H., Guo, Z., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5392128
Tian, Z., Xu, Z., Guo, M., Fang, H., Yang, H., Shao, Q., Wang, D., Jin, F., Gu, Y., Liu, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.21.695762
Self-citationExtracellular Vesicles in Tauopathies: Mechanisms and Applications
Nannuri, V., Ababneh, E., Rayes, S. E., Smith, J., Sugaya, K., & Zhao, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041998 · Cited by 1
Targeting α-Synuclein Pathology Spread Using an α-Synuclein-specific Nanobody
Armstrong, S. E. M. (2022) · TSpace (University of Toronto)
The Role of Exosomes in Spreading Pathology in Synucleinopathies
Hamzeh, A. M. (2022) · TSpace (University of Toronto)
Garland, B., Shen, Z., Chen, M., Gao, B., Mao, K., Richardson, D. R., Mellick, G. D., & Ma, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.01.708908
PISTONE, A. (2026) · CINECA IRIS Institutional Research Information System (University of Basilicata)
Ubiquitin-Proteasome System: Key Insights into Neurological Disorder Mechanisms
Afridi, S., Choudhary, F., Sharma, P., Mustafa, M., & Farooqi, H. (2026) · Current Aging Science · doi:10.2174/0118746098383104251205103934
Crossing the blood–brain barrier: exosomes in neurological research
Prakāsh, C., Saran, S., & Sharma, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00019-1
Extracellular Vesicles in Neurodegenerative Diseases: Tools for Therapy and Regeneration
Bakr, M., Gobba, F., Sabry, M., & Salama, M. (2026) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-032-12705-1_3
Étude de la propagation de l'alpha-synucléine de l'hôte vers le greffon dans la maladie de Parkinson
Patrigeon, M. (2022) · theses.fr (ABES) · doi:10.70675/8d75463az5b67z46bfz8649zc3e016dabdda
Ιmplicatiοn des macrοphages périvasculaires dans les hémοrragies intracérébrales
Bellemain-Sagnard, M. (2025) · theses.fr (ABES) · doi:10.70675/8f114225z5c61z4a53zad29z622b09407daf
Xie, Q., & Yang, B. (2026) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2026.10587
Angiotensin II impairs the remyelination mediated by brain endothelial cell-derived exosomes
Yuan, Y., Liang, S., Guan, A., Sun, J., Shen, W., Dong, Q., Guo, M., & Cui, M. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02288-w
Self-citationLi, Y., Guo, L., Yu, X., & Peng, C. (2026) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.31 · Cited by 1
Engineered Exosomes: Innovative Strategies for Precision Drug Delivery in Parkinson’s Disease
Yuan, X., Wang, C., Yan, J., Wang, J., Li, F., You, Y., & Qi, Z. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05898-6
Self-citationZhang, Q., Qian, X., Peng, T., Hou, X., Ma, Z.-Y., Huang, J., Hu, L., & Luo, W. (2026) · Brain and Behavior · doi:10.1002/brb3.71489
Chen, F., Liang, Y., Li, W., Guo, Y., Liu, H., Geng, M., Liu, M., & Zhang, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104579
Aggad, W. S., Ghosh, R., Almohaimeed, H. M., Mohammedsaleh, Z. M., Saleh, F. M., Almars, A. I., Jyothi, S. R., Panigrahi, R., Kumer, A., & Dhara, B. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70226
Propagation of α-synuclein pathology: models, mechanisms and future goals
Zolin, A., Weber, S. A., Xie, Y. X., & Burré, J. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00038-9
Nannoni, M. (n.d.) · BOA (University of Milano-Bicocca)
Glial control of extracellular α-synuclein propagation in LRRK2 Parkinson’s disease
Datta, I., & Sahu, D. D. (2026) · Advances in immunology · doi:10.1016/bs.ai.2026.04.005
Ahmed, B. Y., Lange, S., Warda, M., Shadidizaji, A., & Onganer, P. U. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135892
Synucleins in Neural Physiology: Understanding Endogenous Function to Better Contextualize Pathology
Sheehan, G. D., & Ding, J. (2026) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-112723-051616
Jaganathan, R., Vijayakumar, S., Chen, Y., Ye, J., Bakthavatchalam, P., Wankhar, D., Yang, C., Iyaswamy, A., & Li, M. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107555
Glial vesicular signaling and Alzheimer’s disease progression
Yadav, K., Sonwani, S., Bana, K., & Tiwari, S. S. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.010
Chen, X., Zhao, T., Zhang, F., Ran, Y., Duan, J., Wang, J., & Liu, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-10238426/v1
Self-citationZhong, S., Chang, X., Liu, H., Cui, F., Jiang, C., & He, S. (2026) · Glial health research. · doi:10.1016/j.ghres.2026.100018
Distinct Transposable Element Transcript Patterns in Microglia Across Aging and Alzheimer's Disease
Grant, R. A., Doser, R. L., & LaRocca, T. J. (2026) · Aging Cell · doi:10.1111/acel.70653
Grant, R. A., LaRocca, T. J., Fling, B. W., Hamilton, K. L., & Moreno, J. A. (2026) · doi:10.25675/3.027494
Exploring the research landscape of exosomes in Parkinson’s disease: a bibliometric analysis
Liu, Y., Liu, Y., Li, Y., Wang, Y., & Liu, J. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1880805
Zhuang, J., Cai, P., Chen, Z., Hong, Q., Wang, R., Wang, F., Zhang, Y., Wu, D., & Chen, F. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06135-w
Liu, X., Chen, L., Zhu, X., Wu, Q., Bu, C., Zheng, F., Yu, G., Hu, H., Guo, Z., Zhou, J., et al. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112318
Lv, S., Xie, J., Huang, X., Liu, Z., Shi, J., Cao, Z., & Shang, Z. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s619730
Liu, H., Chang, X., Wang, L., Lu, W., Yu, C., Du, D., & Guo, W. (2026) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2026.2726549
Extracellular vesicles in neurodegenerative diseases: A new frontier in diagnosis and therapy
Mohammad, S. I., Vasudevan, A., Oriquat, G., Gajjar, T. B., Hanumanthayya, M., Shukla, S. K., Tailor, N. K., Baig, M. R., Fadaam, O., & Abdul, A. S. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116455
LeeBae, J., Bopp, V., Goreth, A., Grozdanov, V., Engels, Z., Kühlwein, J. K., Gazzola, E., Rombach, D., Meier, L., Dimou, L., et al. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00046-9
Boumpoureka, I., Heider, J., Delcambre, S., Borgmann, F. B. K., Poret, A., Boussaad, I., Wilbertz, J. H., Sommer, P., Mittelbronn, M. G. A., Grünewald, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.09.750343
AYDIN, A. C. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06191-2
Chen, J., Zhang, W., Song, L., Liao, Y., Zhang, H., Xia, Y., & Cui, D. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70839
Biomarcadores de Parkinson en humor acuoso y regulación de la microglía en la neuroinflamación
Subías, M. G. (2023) · Rovira & Virgili repository
Lekshmi, S. S. A., Palathingal, M., Manikkath, J., Sarath Chandran, C., & Nampoothiri, M. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.109009
Zhang, H., Zou, J., Zhao, Y., Ruan, Q., 韩瑞琴, Li, C., Liang, Y., & Zhang, Y. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109413
Self-citationGhosh, M., & Pearse, D. D. (2026) · Cells · doi:10.3390/cells15201851
Brain insulin resistance and microglial immunometabolic dysregulation in neurodegenerative diseases
Liu, X., Zhang, X., Su, Y., Guan, G., Luo, X., & Zhang, P. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.2002283
Meade, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.2017355
Liu, X., Xu, S., Zhang, S., Li, W., Chen, J., Zhao, M., Ye, C., Liu, Y., Liu, G., 杜艳军, et al. (2026) · Biomolecules · doi:10.3390/biom16111596
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.